Glenmede Trust Co. NA decreased its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 1.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 565,831 shares of the company’s stock after selling 6,500 shares during the quarter. Glenmede Trust Co. NA owned 0.07% of Colgate-Palmolive worth $58,739,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. E Fund Management Hong Kong Co. Ltd. acquired a new position in Colgate-Palmolive in the 2nd quarter valued at $25,000. Continuum Advisory LLC lifted its position in Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after purchasing an additional 125 shares during the period. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive during the third quarter worth about $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive in the 3rd quarter valued at about $53,000. Finally, Prospera Private Wealth LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $64,000. Institutional investors own 80.41% of the company’s stock.
Analyst Ratings Changes
A number of research analysts recently issued reports on CL shares. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research note on Monday, October 28th. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and upped their price objective for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. TD Cowen decreased their target price on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Finally, Redburn Atlantic raised shares of Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus price target of $105.11.
Insiders Place Their Bets
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.37% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Price Performance
CL stock opened at $96.59 on Wednesday. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company’s fifty day simple moving average is $97.74 and its 200 day simple moving average is $98.59. Colgate-Palmolive has a 12-month low of $75.50 and a 12-month high of $109.30. The firm has a market cap of $78.91 billion, a price-to-earnings ratio of 27.68, a PEG ratio of 3.40 and a beta of 0.42.
Colgate-Palmolive Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $0.50 per share. The ex-dividend date was Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.07%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- What is the Nasdaq? Complete Overview with History
- 2 Generic Drug Stocks Ready to Surge in 2025
- What is a Dividend King?
- 3 Small-Cap Stocks That Are Ready to Rocket Higher
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 2 Essential Data Center Solutions Providers Riding the AI Boom
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.